Decrease Artery Occlusion by Distal Radial Arterial Cannulation, Observational Study
- Conditions
- Outcome, FatalProcedural ComplicationAcute Coronary Syndrome
- Registration Number
- NCT05230719
- Lead Sponsor
- Shenzhen People's Hospital
- Brief Summary
The site of arterial access for coronary angiography and intervention has been the focus of research for decades as it is the source of major complications. Transradial access (TRA) reduces complications among patients undergoing percutaneous coronary procedures but is reported with the complication of radial artery occlusion (RAO) that limits the radial artery for future needs. Distal radial access (dTRA) has recently gained global popularity as an alternative access route for vascular procedures. Among the benefits of dTRA are the low risk of entry site bleeding complications, the low rate of radial artery occlusion, and improved patient and operator comfort. This study aims to reveal the feasibility and safety of dTRA and routine TRA procedures in acute coronary syndrome patients. The primary endpoints are forearm radical occlusion rate and major adverse cardiovascular events (MACEs) in the two groups. Investigators conduct this retrospected analysis to demonstrate the difference of the two procedure of Cannulation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 2000
- presence of a pulse in the snuffbox
- Absence of pulse
- Ultrasound indication of arterial occlusion or severe calcification
- Severe forearm artery malformation
- Patients with severe liver and renal failure, or abnormal coagulation function
- Established cardiogenic shock
- History of previous coronary artery bypass grafting and radial artery use.
- Raynaud's disease in the medical history
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Forearm radical 2 years Doppler ultrasound to determine whether patients suffer forearm radial occlusion
MACEs 2 years Major Adverse Cardiovascular Events, including cardiovascular death, myocardial infarction and heart failure.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Shenzhen People's hospital
🇨🇳Shenzhen, Guangdong, China
Shenzhen People's hospital🇨🇳Shenzhen, Guangdong, ChinaTangzhiming Li, PhD.Contact+86 18588269277litangzhiming@126.comXin Sun, PhD.Contact+86 18126540853sunxinflying@163.comShaohong DongPrincipal Investigator